Aurinia Pharmaceuticals (AUPH) Ownership - Who Owns Aurinia Pharmaceuticals?

2,130 Followers

Aurinia Pharmaceuticals (AUPH) Ownership Overview

13.26% Insiders

4.59% Mutual Funds

18.96% Other Institutional Investors

7.29% ETFs

55.90% Public Companies and

Individual Investors

The ownership structure of Aurinia Pharmaceuticals (AUPH) stock is a mix of institutional, retail, and individual investors. Approximately 30.84% of the company’s stock is owned by Institutional Investors, 13.26% is owned by Insiders, and 55.90% is owned by Public Companies and Individual Investors.

The ownership structure of Aurinia Pharmaceuticals (AUPH) stock is a mix of institutional, retail, and individual investors. Approximately 23.55% of the company’s stock is owned by Institutional Investors, 13.26% is owned by Insiders, and 7.29% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Jun 02, 2026	Kevin Tang	xxxxxxxxxxxxx	$12455227
Aug 05, 2025	Kevin Tang	xxxxxxxxxxxxx	$13590000
Aug 05, 2025	Greg Keenan	xxxxxxxxxxxxx	$210000

Show More Insider Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
13,044,106	Insider	10.14%	206,618,639
5,309,313	Institution	4.13%	84,099,518
1,866,703	Institution	1.45%	29,568,576
1,744,866	Insider	1.36%	27,638,677
1,259,506	Institution	0.98%	19,950,575
1,244,015	Institution	0.97%	19,705,198
738,786	Institution	0.57%	11,702,370
710,464	Institution	0.55%	11,253,750
662,900	Insider	0.52%	10,500,336
621,402	Insider	0.48%	9,843,008

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,866,703	Institution	1.45%	29,568,576
1,244,015	Institution	0.97%	19,705,198
710,464	Institution	0.55%	11,253,750
422,016	Institution	0.33%	6,684,733
336,741	Institution	0.26%	5,333,977
111,924	Institution	0.09%	1,772,876
92,212	Institution	0.07%	1,460,638
86,232	Institution	0.07%	1,365,915
84,000	Institution	0.07%	1,330,560
80,526	Institution	0.06%	1,275,532

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Russell 2000 ETF	2,803,278	Institution	2.18%	44,403,924
iShares Russell 2000 Growth ETF	984,322	Institution	0.77%	15,591,660
iShares Biotechnology ETF	858,780	Institution	0.67%	13,603,075
Vanguard Russell 2000 ETF	603,296	Institution	0.47%	9,281,709
Janus Henderson Small/Mid Cap Growth Alpha ETF	546,669	Institution	0.43%	8,659,237
Vanguard Health Care ETF	337,211	Institution	0.26%	5,187,991
Fidelity Enhanced Small Cap ETF	313,900	Institution	0.24%	5,138,543
Avantis U.S Small Cap Equity ETF	241,157	Institution	0.19%	3,947,740
Janus Henderson Small Cap Growth Alpha ETF	193,348	Institution	0.15%	3,062,632
Principal U.S. Small-Cap Multi-Factor ETF	121,730	Institution	0.09%	1,992,720

FAQ

Who Owns Aurinia Pharmaceuticals (AUPH)?

According to the latest TipRanks data, approximately 18.96% of the company's stock is held by institutional investors, 13.26% is held by insiders, and 55.90% is held by retail investors.

What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors?

According to the latest TipRanks data, approximately 18.96% of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors.

What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors?

According to the latest TipRanks data, approximately 55.90% of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors.

Who owns the most shares of Aurinia Pharmaceuticals (AUPH)?

Kevin Tang owns the most shares of Aurinia Pharmaceuticals (AUPH).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.